대한부인종양학회

최신 논문

총 게시글 : 156

First-Line Lenvatinib Plus Pembrolizumab Versus Chemotherapy for Advanced Endometrial Cancer: A Randomized, Open-Label, Phase III Trial. 2025-03-20 VIEW : 0
Pembrolizumab in microsatellite instability-high/mismatch repair deficient (MSI-H/dMMR) and non-MSI-H/non-dMMR advanced endometrial cancer: Phase 2 KEYNOTE-158 study results. 2025-03-20 VIEW : 2
Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial. 2025-03-20 VIEW : 4
Assessment of malignant potential for HPV types 16, 52, and 58 in the uterine cervix within a Korean cohort 2024-09-24 VIEW : 42
Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning 2024-09-24 VIEW : 10
Initial sarcopenia and body composition changes as prognostic factors in cervical cancer patients treated with concurrent chemoradiation: An artificial intelligence-based volumetric study 2024-09-24 VIEW : 0
GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 tria 2024-09-24 VIEW : 10
Outcomes of extended progestin therapy in atypical endometrial hyperplasia patients without an initial response to progestin: a retrospective study from two tertiary centers in Korea and Taiwan 2024-09-24 VIEW : 9
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study 2024-09-24 VIEW : 13
Choosing the right adjuvant therapy for stage III–IVA endometrial cancer: A comparative analysis of chemoradiotherapy and chemotherapy 2024-09-24 VIEW : 1
Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysis 2024-09-24 VIEW : 3
Comparison of Outcomes in Bowel Resections by Gynecologic Oncologists Versus General Surgeons During Maximal Cytoreductive Surgery for Advanced Ovarian Cancer: Gynecologic Oncology Research Investigators Collaboration Study (GORILLA-3006). 2024-09-24 VIEW : 9
Durvalumab with or without tremelimumab plus chemotherapy in HRR non-mutated, platinum-resistant ovarian cancer (KGOG 3045): A phase II umbrella trial. 2024-09-24 VIEW : 3
Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer. 2024-09-24 VIEW : 9
Serial Circulating Tumor DNA Analysis with a Tumor-Naïve Next-Generation Sequencing Panel Detects Minimal Residual Disease and Predicts Outcome in Ovarian Cancer. 2024-09-24 VIEW : 1

1
2
3
4
5
6
7
8
9
10
11